Back
Palo Alto Networks Vs. Akero Therapeutics Industry Stock Comparison
Sell
40
PANW
Palo Alto Networks
Last Price:
$167.06
Seasonality Move:
4.68%
Buy
57
AKRO
Akero Therapeutics
Last Price:
$50.47
Seasonality Move:
22.59%
Sell
40
Palo Alto Networks (PANW)
is a Sell
Is Palo Alto Networks a Buy, Sell or Hold?
-
The current Palo Alto Networks [PANW] share price is $167.06. The Score for PANW is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
PANW is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $50.46. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PANW Stock Price Chart
What is Palo Alto Networks's stock price today?
-
The Palo Alto Networks share price today is $167.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PANW is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $50.46The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
PANW Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 47.17 | Buy |
Relative Strength Index (14 RSI): | 29.82 | Sell |
Chaikin Money Flow: | -7317520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (176.53 - 202.25) | Sell |
Bollinger Bands (100): | (173.52 - 199.66) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 49.27 | Sell |
Chaikin Money Flow: | 48890 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.1 - 52.56) | Sell |
Bollinger Bands (100): | (40.67 - 52.97) | Buy |
PANW Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 172.21 | Sell |
20-day SMA: | 187.19 | Sell |
50-day SMA: | 193.78 | Sell |
200-day SMA: | 187.62 | Sell |
8-day EMA: | 153.25 | Buy |
20-day EMA: | 102.71 | Buy |
50-day EMA: | 52.59 | Buy |
200-day EMA: | 15.01 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.6 | Buy |
20-day SMA: | 50.71 | Sell |
50-day SMA: | 52.15 | Sell |
200-day SMA: | 41.43 | Buy |
8-day EMA: | 50.18 | Buy |
20-day EMA: | 50.51 | Sell |
50-day EMA: | 50.17 | Buy |
200-day EMA: | 42.74 | Buy |
Palo Alto Networks Earnings Growth & PANW Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.05 per share, an increase this year of $0.49 per share, and an increase next year of $0.41 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.58 per share.
Palo Alto Networks Technical Analysis
Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |